CAAS Capital Management’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-30,675
Closed -$10.4K 554
2024
Q1
$10.4K Hold
30,675
﹤0.01% 475
2023
Q4
$7.05K Hold
30,675
﹤0.01% 449
2023
Q3
$5.06K Hold
30,675
﹤0.01% 605
2023
Q2
$4.73K Hold
30,675
﹤0.01% 640
2023
Q1
$3K Hold
30,675
﹤0.01% 671
2022
Q4
$1.84K Hold
30,675
﹤0.01% 716
2022
Q3
$2K Hold
30,675
﹤0.01% 774
2022
Q2
$8K Hold
30,675
﹤0.01% 801
2022
Q1
$12K Hold
30,675
﹤0.01% 587
2021
Q4
$20K Hold
30,675
﹤0.01% 797
2021
Q3
$21K Buy
+30,675
New +$24.5K ﹤0.01% 872

Other funds holding AONCW

CAAS Capital Management's AONCW Position: Q2 2024 in Review

CAAS Capital Management sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 30,675 shares — an estimated $10.4K sold.

CAAS Capital Management first reported a position in AONCW in Q3 2021 and held it in 11 quarters. The position peaked at $21K in Q3 2021. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

  • CAAS Capital Management reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
  • CAAS Capital Management sold 30,675 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $10.4K.
  • CAAS Capital Management first reported a position in American Oncology Network, Inc. Warrant in Q3 2021 and held it in 11 quarters.
  • CAAS Capital Management's American Oncology Network, Inc. Warrant position peaked at $21K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on CAAS Capital Management's 13F filing for Q2 2024, filed 15 Jul 2024.